More on VRXA

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Veraxa Biotech AG (NQ:VRXA)
Delayed: 1.75 +0.22 (14.38%)
Prev. Close $1.53  
Open$1.57 
52 Wk High$ 
52 Wk Low$ 
Day High$1.97 
Day Low$1.53 
P/E N/A  
EPS$ 
Volume3,375,486 

Friends, Peers and Foes (?): VACH OABI (more...)

Sep 4, 2026 07:00 AM Veraxa Biotech names Raju Willener as CFO
Sep 4, 2026 07:00 AM VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
Aug 24, 2026 07:39 AM Form 6-K Veraxa Biotech AG - Post For: Aug 24
Aug 24, 2026 07:01 AM Veraxa Biotech and Secarna report early AOC research milestone
Aug 24, 2026 07:00 AM VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
Aug 20, 2026 04:00 PM Form 3 Veraxa Biotech AG - Post For: Jul 10 Filed by: von Halem Carl
Jul 31, 2026 05:16 PM Veraxa Biotech AG (VRXA) files for 25M share offering by selling stockholders
Jul 29, 2026 07:03 AM VERAXA Biotech files first BiTAC patent applications, portfolio tops 50
Jul 29, 2026 07:00 AM VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
Jul 27, 2026 07:00 AM VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
View All Articles

Entities mentioned with vrxa

View All Entities